on 10 Jan 2008
Last Applicant/ Owned by
Protalix Ltd.
2 Snunit Street, Science Park
Carmiel, , 20100
Serial Number
UK00906570493 filed on 10th Jan 2008
Registration Number
UK00906570493 registered on
19th Mar 2009
Correspondent Information
Mathys & Squire LLP
The Shard, 32 London Bridge Street
London,
SE1 9SG
Chemical, biochemical, biological and biotechnological preparations and substances for producing biopharmaceuticals, namely recombinant proteins; chemical, biochemical and biotechnological preparations and substances for industrial and scientific use, namely, recombinant vectors for cloning and expression of DNA; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of recombinant proteins, namely, recombinant vectors for cellular expression of recombinant DNA; chemical, biochemical, biological and biotechnological preparations and substances for supporting cellular expression of recombinant proteins, namely , cell growth support structures medium and substrates for use in cell cultures; chemical, biochemical, biological and biotechnological preparations and substances for use in the manufacture of recombinant protein based products, namely, medicines, pharmaceuticals, diagnostics, vaccines, antibodies and biological molecules; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for industrial and scientific research use in laboratories, diagnostics and analytics.
Chemical, biochemical and biotechnological preparations and substances for medical use, namely, recombinant vectors for cloning and expression of DNA; chemical, biochemical, biological and biotechnological preparations and substances, namely, recombinant vectors for medical research use in laboratories, diagnostics and analytics.
Bioreactor for cell culturing; apparatus for culturing and harvesting of plant cells capable of expressing recombinant proteins.
Providing a system for culturing plant cells used to produce biopharmaceuticals, namely, recombinant proteins; research and development for others in the field of genetically engineered plants and plant cell for producing biopharmaceuticals, namely recombinant proteins; development of new technology for the others in the field of recombinant biotechnology; product research and development; scientific research and industrial research for others, namely, drug discovery, cell discovery, discovery of recombinant proteins, gene research, enzyme research, molecular research, genomics and gene expression research and development; technical consultation in the field of biotechnology and in the field of recombinant production technology.
UK00906570493
Word
Individual